TobaccoReporter logo

Tag: stock

  • Cabbacis Hosting Webinar Outlining its $7.5M Offering

    Cabbacis Hosting Webinar Outlining its $7.5M Offering

    Cabbacis announced it will host an investor webinar on January 22 at 11:30 EST as part of its ongoing $7.5 million Regulation A offering. During the session, CEO and chairman Joseph Pandolfino will outline the company’s commercialization strategy for its patented iBlend cigarettes and vaporizer pods, which combine very-low-nicotine tobacco with non-intoxicating hemp and are positioned as harm-reduction products aimed at reducing nicotine dependence and supporting quit attempts.

    The company will also update investors on its regulatory pathway with the U.S. Food and Drug Administration, leadership team, and plans for an international rollout later in 2026 to generate early revenue and brand validation ahead of U.S. market entry. Cabbacis said proceeds from the offering are intended to support product development and commercialization, positioning the company ahead of a potential FDA rule to cap nicotine levels in cigarettes, while expanding into reduced-nicotine and alternative tobacco formats.

    Register for the webinar here.

  • Indian Tobacco Stocks Slide After New Tax Announced

    Indian Tobacco Stocks Slide After New Tax Announced

    Shares of Indian tobacco companies fell sharply after the government imposed a new excise duty on cigarettes, raising costs for an estimated 100 million smokers. Market leader ITC dropped more than 9%, hitting its lowest level since April 2023, while Godfrey Phillips India, distributor of Marlboro, sank over 14% in its steepest fall in nearly a decade. The sell-off made ITC the biggest decliner on the Nifty 50 and dragged down the FMCG index.
    India’s finance ministry said the new excise duty, effective February 1, will range from 2,050 to 8,500 rupees per 1,000 cigarette sticks, depending on length, on top of the existing 40% Goods and Services Tax. Analysts said the move could raise overall costs for some cigarette categories by 22% to 28%, likely prompting price hikes of 2–3 rupees per stick for longer cigarettes.
    Brokerages warned the tax increase could pressure volumes and revive concerns about a shift toward illicit cigarettes.

  • China Boton Suspends Stock Trading

    China Boton Suspends Stock Trading

    Shares of China Boton Group Company Limited were temporarily suspended from trading on the Hong Kong Stock Exchange today (December 2025), pending the release of an announcement concerning a “very substantial disposal” under listing rules. The company said the halt is required to comply with disclosure obligations and will remain in place until further notice. Details of the proposed transaction have not yet been disclosed.

    The announcement came from board chairman Wang Mingfan, who said further information will be published once the transaction announcement is ready. Boton is one of China’s largest extract and fragrance companies, and supplies flavorings for the global tobacco and nicotine sector.

  • BAT Launches Tender Offer for €1 Billion Hybrid Securities

    BAT Launches Tender Offer for €1 Billion Hybrid Securities

    BAT announced a cash tender offer for its €1 billion Perpetual Subordinated Fixed-to-Reset Rate Non-Call 5.25 Year Securities, carrying a 3% coupon and a first optional redemption date in late 2026. The company is offering to purchase all of the securities at 100.375% of face value, plus accrued interest. The move is part of BAT’s plan to proactively manage its hybrid capital portfolio, alongside the planned issuance of new euro-denominated hybrid capital securities. The tender offer runs until October 28 at 4 p.m. BST, with settlement expected on October 31.

    If BAT purchases 75% or more of the outstanding securities, it may exercise its option to redeem the remaining notes at par. Securities acquired in the offer will be cancelled. The transaction is not open to U.S. investors and remains subject to a New Financing Condition linked to the success of the new bond issuance.

  • Defiance ETFs Launches 2X Philip Morris Fund

    Defiance ETFs Launches 2X Philip Morris Fund

    Defiance ETFs introduced the “Defiance Daily Target 2X Long PM ETF,” an exchange-traded fund (ETF) under the NYSE symbol ZYN. The company clarified that the investment was not a purchase of Philip Morris International (PMI) stock, but an investment in a fund that offers investors twice the daily exposure to PMI. The leveraged product uses swaps and options to achieve its objectives, giving retail investors access to amplified PMI performance without the need for margin accounts.

    PMI, Defiance said, is positioning itself for a future beyond combustible cigarettes, and that the launch reflects investor appetite for targeted exposure to global tobacco majors as they expand their portfolios into smoke-free categories. Defiance said ZYN is designed for sophisticated investors who understand the risks of daily leveraged funds.

  • SEC Approves Cabbacis to Sell Stock

    SEC Approves Cabbacis to Sell Stock

    Cabbacis, a U.S.-licensed tobacco-product manufacturer focused on harm-reduction products that produces the iBlend brand, announced that the U.S. Securities and Exchange Commission (SEC) qualified the company’s offering statement on Form 1-A for a Regulation A (Tier 2) offering. The company seeks to raise $7 million through the public sale of its common stock at $2 per share.

    The company said it will use the proceeds for product development and commercialization expenses, including FDA costs related to filing premarket tobacco product applications (PMTAs) for the U.S. market, tobacco and hemp plantings, general corporate purposes, and potential acquisitions.

    “Cabbacis is committed to commercializing reduced-nicotine cigarettes and vaporizer pods,” the company said in a press release. “Both types of products in development are predominantly tobacco and include hemp. The company also plans to move forward with reduced-nicotine tobacco cigarettes (and little cigars) without hemp.”

    Cabbacis holds 35 issued patents in more than 15 countries, including seven in the United States. Access to the offering is available at www.cabbacis.com, where the offering circular and subscription agreement are publicly accessible.

  • BAT’s Block Listing Application and Cancellation

    BAT’s Block Listing Application and Cancellation

    Today (Feb. 27), British American Tobacco announced it made an application to the Financial Conduct Authority and the London Stock Exchange for a block listing totaling 1.5 million ordinary shares of 25p each to be admitted to the equity shares category of the Official List and to trade on the main market of the London Stock Exchange.

    The shares will be issued pursuant to the BAT Sharesave Scheme. Upon issuance, the shares shall rank equally with the existing issued shares of the company. The admission of the shares is expected on March 3, 2025.

    BAT further announced that it currently has 31,189 ordinary shares of 25p each block listed under the British American Tobacco Executive Share Option Scheme. No allotments have been made under the Scheme since the last block listing return was released Jan. 1, 2025. All outstanding options under the Scheme have now been exercised and the Scheme has closed. As a result, the block listing associated with the Scheme has been cancelled.

  • BAT Shares Tumble 9%

    BAT Shares Tumble 9%

    Today, British American Tobacco shares dropped 9% in London on news it would take a $7.74 billion hit from a Canadian lawsuit as well as fears that changes in Bangladesh and Australia would hurt its performance in 2025. The $6 billion loss off its market capitalization was the company’s worst day on the market since 2020. BAT’s stock remains up 7% since the start of the year.

    Under the proposed Canadian settlement, an upfront payment will be followed by annual payments, initially worth 85% of net income after taxes, excluding income related to alternative products like vapes, and reducing over time. BAT and other tobacco companies were set to pay $22.8 billion to settle a long-running case in Canada, but some parties, including Philip Morris International’s Canadian affiliate, have since objected to the proposal.

    Meanwhile, BAT said new tobacco regulations in Australia and increased excise and VAT in Bangladesh would hurt its tobacco business.

    Chief Executive Officer Tadeu Marroco said these represented “significant regulatory and fiscal headwinds” that would dent its performance this year, but their impact would recede into 2026 when BAT’s investments would also pay off to spur growth. For 2025, the company expects just 1% revenue growth.

    Marroco also said he was hopeful U.S. President Donald Trump’s new administration could tackle sales of illegal disposable vapes, which have impacted its cigarette and vape sales in the country. “We remain committed to returning to our mid-term guidance of 3% to 5% revenue and 4% to 6% adjusted profit from operations growth on a constant currency in 2026,” he said.

  • Universal Corporation Announces Quarterly Dividend

    Universal Corporation Announces Quarterly Dividend

    Universal Corporation announced that the Company’s Board of Directors declared a quarterly dividend of eighty-one cents ($0.81) per share on the common shares of the Company, payable May 5, 2025, to common shareholders of record at the close of business on April 14, 2025.

    Universal Corporation is a global agricultural company with more than 100 years of experience supplying products and innovative solutions to meet customers’ evolving needs and precise specifications. Universal works with farmers and partners across more than 30 countries on five continents.

  • Busy Day for BAT Stocks

    Busy Day for BAT Stocks

    British American Tobacco (BAT) executed a share buyback program January 27, purchasing 129,541 ordinary shares at an average price of £29.951908 per share. According to TipRanks, this move, authorized by shareholders, “is part of its broader strategy to enhance shareholder value by reducing the number of shares in circulation, which could potentially impact the company’s stock value and stakeholder interests.”

    Later in the day, the stock rallied to £31.50 on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index. According to MarketWatch, that price was a 52-week high for BAT, surpassing the £30.47 from January 24.